Graham v. Octapharma Plasma Inc

CourtDistrict Court, W.D. Louisiana
DecidedMarch 24, 2020
Docket3:18-cv-01654
StatusUnknown

This text of Graham v. Octapharma Plasma Inc (Graham v. Octapharma Plasma Inc) is published on Counsel Stack Legal Research, covering District Court, W.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Graham v. Octapharma Plasma Inc, (W.D. La. 2020).

Opinion

UNITED STATES DISTRICT COURT

WESTERN DISTRICT OF LOUISIANA

MONROE DIVISION

JAMES DOUGLAS GRAHAM CIVIL ACTION NO. 18-1654

VERSUS JUDGE TERRY A. DOUGHTY

OCTAPHARMA PLASMA, INC., ET MAG. JUDGE KAREN L. HAYES AL.

RULING

This is a personal injury lawsuit brought by James Douglas Graham (“Graham”) against Defendant Octa-Pharma Plasma, Inc. (AOcta-Pharma@). On February 7, 2020, Octa-Pharma filed a Motion for Summary Judgment [Doc. No. 30]. Octa-Pharma moves the Court grant judgment in its favor as a matter of law because Graham lacks sufficient evidence to raise a genuine issue of material fact for trial on causation. Graham opposes summary judgment. [Doc. No. 38]. Octa- Pharma has filed a reply. [Doc. No. 40]. For the following reasons, Octa-Pharma’s Motion for Summary Judgment is GRANTED, and Graham’s claims are DISMISSED WITH PREJUDICE. I. FACTS On August 28, 2017, Graham donated plasma at Octa-Pharma’s Monroe, Louisiana center. Graham frequently donated plasma, estimating he had done so approximately 250 times. On this date, he claims that the phlebotomist missed his vein several times trying to perform venipuncture on his right arm. At some point, Graham contends that he suffered excruciating pain causing him to scream out. Graham did not leave, however, but remained at the center and completed his 1 plasma donation. Two days after his donation, on August 30, 2017, Graham returned to Octa-Pharma to complain of a hematoma and numbness and tingling in his arm. The following day, August 31, 2017, Graham saw a health care practitioner for the first time. Graham went to the Forsythe Family Medical Clinic where he was seen by Angela Hamby, an Advanced Practice Registered Nurse (“APRN”). He complained of pain and loss of use of his right arm. On or about September 28, 2017, Hamby referred Graham to occupational therapy, but he

did not begin occupational therapy until November 28, 2017, two months later. He was discharged from occupational therapy in January 31, 2018, but still had complaints of pain in his right hand and elbow, as well as numbness from his elbow down to the last two digits of his right hand. Hamby referred Graham to other practitioners because Graham’s right arm complaints were “out of [her] scope.” [Doc. No. 30-8, November 13, 2019 Deposition of Angela Hamby, N.P, pp. 16]. Hamby is not qualified to make any determination as to whether or not Graham has nerve damage. Id. at pp. 24-25. Hamby made no diagnosis of Graham’s injury. Id. at pp. 22-23. Hamby does not know what, if any, of Graham’s nerves were damaged and has “no opinion” as to what nerves were damaged. Id. at p. 24. Instead, Hamby would ultimately defer to the neurologist who treated Graham as to whether or not Graham’s injuries were caused by the plasma donation. Id. at pp. 24-25, 40-41, 42, 44, 50-51, 63, 64-65, 79. On October 1, 2018, more than a year after the alleged incident, Graham saw neurologist, Dr. Vijayakumar Javalkar at Ochsner-LSU Shreveport. [Doc. No. 30-9, November 13, 2019 Deposition of Dr. Vijayakumar Javalkar]. Dr. Javalkar is a board-certified general neurologist, with a specialty certification in vascular neurology. Dr. Javalkar also serves as an Assistant 2 Professor of Neurology. Dr. Javalkar noted that Graham had impaired sensation in the medial aspect of his right forearm, atrophy of the muscles in both Graham’s right and left hand, as well as muscle wasting in the muscles in both of Graham’s forearms. Id. at pp. 25, & 77. Dr. Javalkar’s initial possible diagnoses of Graham’s injury were neuropathy, cervical myelopathy, and ALS (Lou Gehrig’s disease). Id. at pp. 62-63. He did not include venipuncture in his differential diagnoses because there was no indication to support that possibility. Id. at pp. 63-64. He ordered an electrodiagnostic study on Graham, which was conducted on November 5, 2018.

Despite Dr. Javalkar’s request for follow-up visits, including further diagnostic testing, Graham never went back to see Dr. Javalkar and has sought no further treatment or diagnosis of his alleged nerve injury. Dr. Javalkar testified that the intense pain described by Graham at the time of the venipuncture is consistent with acute damage to his median nerve, but he cannot determine what has caused Graham’s symptoms and whether Graham had traumatic neuropathy– like that from a venipuncture. Id. at pp. 81. According to Dr. Javalkar, the diffuse atrophy he saw in Graham would not typically be seen from acute trauma like a needle stick, but more typically there would be more isolated symptoms if neuropathy was caused by a needle stick. Id. at pp. 25-26. According to Dr. Javalkar, Graham not only had diffuse atrophy of multiple muscles, but he also had indications that at least two nerves were affected in his right arm, the median nerve and the ulnar nerve. Id. at pp. 25 & 77. This caused Dr. Javalkar to be unsure and unable to conclude that the August 28, 2017 venipuncture caused Graham’s injuries. Id. at pp. 25-26 & 77. Dr. Javalkar also does not know what caused the wasting of the small muscles in Graham’s right hand. Id. at pp. 60-61. Although Dr. Javalkar offered Graham a differential diagnosis, which were the multiple possible causes of Graham’s symptoms, none of those potential diagnoses included venipuncture. 3 Instead, Dr. Javalkar’s differential diagnoses included cervical myelopathy, compression of the spinal cord, ALS, a spinal cord disease, and general neuropathy. Id. at pp. 62-63. According to Dr. Javalkar, diabetes could have caused at least some of Graham’s symptoms. Id. at pp. 29, 36 & 44. Prior to the August 28, 2017 plasma donation, Graham had a number of health conditions and diagnoses: sciatica, cervical myelopathy, degenerative disc disease in his thoracic and lumbar spine, diabetes, and had complaints of right shoulder pain and mid-back pain from a motorcycle wreck. Additionally, Graham had prior diagnoses of mental conditions, including depression,

schizophrenia, and dementia. Graham relies on an expert report from Registered Nurse Mark E. Fuller, who opines:

After thoroughly reviewing the afore mentioned documents, it is my professional opinion that James Douglas Graham did in fact suffer a severe and debilitating nerve injury in the right upper extremity due to the negligence of the Octapharma employee, Paula Hillard, who performed his venipuncture on August 28, 2017. . . .Mr. Graham’s description of symptoms including but not limited to severe pain, weakness, numbness, tingling, progressive loss of function, and muscle wasting are consistent with a severe nerve injury caused by improper venipuncture technique well outside the preferred, safest area for venous access.

[Doc. No. 30-15, Fuller Expert Report]. However, Fuller was subsequently deposed and admitted as follows: • He could not rule out cervical nerve compression as the cause for Graham’s symptoms;

• Fuller did not rule out any other cause for Graham’s symptoms;

• Fuller’s opinion as to the extent of Graham’s injury is “a guess” and “speculation”;

• Fuller has “no idea” if the method he used to make his determination as to the cause of Graham’s symptoms is accepted and used in peer review scientific or medical 4 literature, and has reviewed nothing that has;

• Fuller does “not have an opinion as to what nerve was allegedly injured during the plasma donation;

• Fuller is “not giving an opinion as to the diagnosis of Mr. Graham” because he “can’t diagnose.”;

• A neurologist would be “more qualified” than he to make the determination as to the cause of Graham’s symptoms;

• Fuller never attended medical school, is not a doctor, is not a neurologist, does not specialize in vascular neurology, and is not an expert in neurology;

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ruiz v. Whirlpool, Inc.
12 F.3d 510 (Fifth Circuit, 1994)
Norman v. Apache Corp.
19 F.3d 1017 (Fifth Circuit, 1994)
Vargas v. Lee
317 F.3d 498 (Fifth Circuit, 2003)
Turner v. Baylor Richardson Medical Center
476 F.3d 337 (Fifth Circuit, 2007)
Erie Railroad v. Tompkins
304 U.S. 64 (Supreme Court, 1938)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Lucas v. Ins. Co. of North America
342 So. 2d 591 (Supreme Court of Louisiana, 1977)
Miller v. Tulane University Hospital
38 So. 3d 1142 (Louisiana Court of Appeal, 2010)
Morris v. Orleans Parish School Bd.
553 So. 2d 427 (Supreme Court of Louisiana, 1989)
Richard v. Walgreen's Louisiana Co.
476 So. 2d 1150 (Louisiana Court of Appeal, 1985)
Maranto v. Goodyear Tire & Rubber Co.
650 So. 2d 757 (Supreme Court of Louisiana, 1995)
Villavaso v. State Farm Mut. Auto. Ins. Co.
424 So. 2d 536 (Louisiana Court of Appeal, 1982)
American Motorist v. American Rent-All
579 So. 2d 429 (Supreme Court of Louisiana, 1991)
Housley v. Cerise
579 So. 2d 973 (Supreme Court of Louisiana, 1991)
Aucoin v. State Farm Mut. Auto. Ins. Co.
505 So. 2d 993 (Louisiana Court of Appeal, 1987)
Mart v. Hill
505 So. 2d 1120 (Supreme Court of Louisiana, 1987)
Gasperini v. Center for Humanities, Inc.
518 U.S. 415 (Supreme Court, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Graham v. Octapharma Plasma Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/graham-v-octapharma-plasma-inc-lawd-2020.